Krishna Institute of Medical Sciences Ltd
NSE:KIMS

Watchlist Manager
Krishna Institute of Medical Sciences Ltd Logo
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Watchlist
Price: 670.1 INR 1.14% Market Closed
Market Cap: 268.1B INR

Krishna Institute of Medical Sciences Ltd
Investor Relations

Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions.

The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Nov 10, 2025
AI Summary
Q2 2026

Revenue Growth: KIMS Hospital reported strong Q2 revenue of INR 965 crores, up 23.3% year-on-year and 9.8% quarter-on-quarter.

EBITDA & PAT Decline: Despite revenue growth, EBITDA fell 6.7% YoY and PAT dropped 40.3% YoY due to losses from newly opened hospitals that have yet to break even.

Margins Pressured: EBITDA margin declined to 21.6% from 28.5% YoY, with management expecting margins to stay in the low 20s for the next two quarters before improving as new hospitals ramp up.

Hospital Expansion: Significant bed capacity was added in the past year, with further expansion underway in Telangana, Andhra Pradesh, and new hospitals in Maharashtra and Karnataka.

New Hospital Ramp-Up: Management reiterated that all new hospitals, except one in Bangalore, are expected to be EBITDA neutral within 12 months of commissioning.

Insurance & CGHS: Insurance empanelment delays have affected ramp-up in new markets, but efforts are ongoing; a 15–20% CGHS price hike is expected to benefit margins, with impact seen from Q4.

Cluster Performance: Telangana remains a mature, slower-growth market; Andhra Pradesh shows strong margin expansion, aided by new capacity and acquisitions.

Strategic Focus: KIMS aims to maintain affordable pricing, invest in technology, and expand specialty services to drive volume growth in new markets.

Key Financials
Revenue
INR 965 crores
EBITDA
INR 208 crores
EBITDA Margin
21.6%
PAT
INR 72 crores
EPS
INR 1.67
Cash and Cash Equivalents
INR 120 crores
Consolidated Revenue from Operations
INR 961 crores
Consolidated EBITDA (pre-INDAS)
INR 201 crores
Consolidated EBITDA (pre-INDAS, excluding other income)
INR 197 crores
Average Revenue Per Operating Bed (ARPOB)
INR 42,016
IP Volume
64,288
OP Volume
592,725
Other Earnings Calls

Management

Dr. Bhaskara Rao Bollineni
Founder, Chairman & MD
No Bio Available
Dr. Abhinay Bollineni
CEO & Executive Director
No Bio Available
Mr. Sachin Ashok Salvi
Chief Financial Officer
No Bio Available
Ms. Anitha Dandamudi
Director of Operations & Wholetime Director
No Bio Available
Mr. Uma Shankar Mantha
Company Secretary, Compliance Officer & GM of Legal
No Bio Available
Mr. A. Rajender
Finance Controller
No Bio Available

Contacts

Address
TELANGANA
Secunderabad
1-8-31/1, Minister Rd, Krishna Nagar Colony, Begumpet
Contacts